Item
CALCIUM ASCORBATE TIANLI (6226100 215 02M)
Nutrient / Vitamin
Attributes
- Gluten-free
Locations
| Location name | Address |
|---|---|
| Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | South of Weigao Road, East of Xierhuan Road (Chenming Industrial Park) Shouguang, Weifang, SD 262700 CHN |
| Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Chenming Industrial Park Shouguang, SD 1 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Phthalate Esters Letter | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | 0326.pdf | 8/9/2021 | 8/9/2022 |
| Food Contact Packaging Certificate of Compliance | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | 20167-.pdf | 5/13/2022 | 5/12/2024 |
| Food Contact Packaging Certificate of Compliance | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | 20167-.pdf | 5/13/2022 | 5/12/2024 |
| CoA Sample | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | 6226100 CALCIUM ASCORBATE Lot 032007922.pdf | 5/16/2022 | 5/15/2024 |
| Allergens | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Allergens.pdf | 2/23/2022 | 2/23/2024 |
| Allergens | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Allergens.pdf | 2/23/2022 | 2/23/2024 |
| Animal Testing Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Animal Free Source Statement--VC CA.pdf | 7/30/2021 | 7/30/2023 |
| No Animal Ingredient Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Animal Statement.pdf | 8/9/2021 | 8/9/2022 |
| Animal Testing Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Animal testing Statement.pdf | 12/24/2023 | 12/23/2025 |
| Pesticide | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | C--.pdf | 7/21/2020 | 7/21/2022 |
| CoA Sample | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | COA-032310902.pdf | 10/13/2023 | 10/12/2025 |
| Ingredient Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | COMPOSITION DATASHEET Calcium Ascorbate.pdf | 6/11/2021 | 6/11/2022 |
| Country of Origin | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Country of Origin.pdf | 2/17/2020 | 2/16/2023 |
| Country of Origin | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Country of Origin.pdf | 11/26/2023 | 11/25/2026 |
| Dietary Supplement Questionnaire | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Dietary Supplement Questionnaire.pdf | 5/24/2022 | 5/24/2023 |
| Dietary Supplement Questionnaire | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Dietary Supplement Questionnaire.pdf | 12/24/2023 | 12/23/2024 |
| HACCP Process Flow Diagram | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Flow Chart of Calcium Ascorbate.pdf | 6/3/2020 | 6/3/2022 |
| HARPC Food Safety Plan (Item) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Food safety plan Statement.pdf | 11/27/2023 | 11/26/2026 |
| HARPC Food Safety Plan (Item) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | FSSC22000.pdf | 6/3/2020 | 6/3/2023 |
| FSVP Assessment Form | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | FSVP Assessment Form.pdf | 5/24/2022 | 5/24/2023 |
| Gluten | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Gluten Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| Gluten | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Gluten Statement.pdf | 5/24/2022 | 5/24/2023 |
| GRAS/NDI/ODI Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | GRAS Statement.pdf | 5/13/2020 | 5/13/2023 |
| GRAS/NDI/ODI Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | GRAS Statement.pdf | 12/24/2023 | 12/23/2026 |
| Heavy Metal | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Heavy Mental Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| Halal | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | IFANCE HALAL-2024-VC.pdf | 4/6/2022 | 3/31/2024 |
| Halal | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | IFANCE HALAL-2024-VC.pdf | 4/6/2022 | 3/31/2024 |
| Ingredient Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Ingredient Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| Irradiation Status Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Irradiation (IRR)Ionization Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| HACCP | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | ISO 22000.jpg | 5/13/2020 | 5/13/2023 |
| Item Questionnaire | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Item Questionnaire.pdf | 2/23/2022 | 2/22/2025 |
| Item Questionnaire | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Item Questionnaire.pdf | 2/23/2022 | 2/22/2025 |
| Kosher | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | LM-QC-TLV-003-2022A-Kosher.pdf | 5/24/2022 | 5/31/2023 |
| GMO | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | LM-QC-TLV-006-2022A-IP(Tianli).pdf | 9/15/2021 | 9/15/2023 |
| HACCP Process Flow Diagram | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-03-001-2023A-MFC-VC CA.pdf | 1/31/2023 | 1/30/2025 |
| Label Sample | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-03-001-2023A-PACK.pdf | 12/24/2023 | 12/23/2024 |
| Safety Data Sheet (SDS) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-03-001-2023A-SDS.pdf | 1/1/2023 | 12/31/2025 |
| Product Specification Sheet | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-03-001-2023A-SPEC-VC CA.pdf | 1/1/2023 | 12/31/2025 |
| HACCP | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QS-03-001-2023A-HACCP.pdf | 12/28/2022 | 12/27/2025 |
| Lot Code | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | lot code explanation- VC-CA-03.pdf | 12/13/2023 | 12/12/2026 |
| Lot Code | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Lot Code.pdf | 6/3/2020 | 6/3/2023 |
| Melamine | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Melamine Free Statement--VC CA.pdf | 7/30/2021 | 7/30/2022 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | National Bioengineered Food Disclosure Standard (Simplified).pdf | 6/3/2020 | 6/3/2023 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | National Bioengineered Food Disclosure Standard (Simplified).pdf | 12/24/2023 | 12/23/2026 |
| No Animal Ingredient Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | No Animal Ingredient Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| EtO Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Non ETO Statement.pdf | 5/13/2022 | 5/12/2024 |
| EtO Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Non ETO Statement.pdf | 5/13/2022 | 5/12/2024 |
| Natural | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Non- Natural Statement-VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| GMO | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | non-GMOStatement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| Irradiation Status Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | non-irradiation.pdf | 6/3/2020 | 6/3/2022 |
| Organic | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | NotApplicable_Organic.pdf | 6/3/2020 | -- |
| Organic | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | NotApplicable_Organic.pdf | 6/3/2020 | 6/3/2022 |
| Nutrition | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Nutrition.pdf | 2/17/2020 | 2/16/2023 |
| Nutrition | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Nutrition.pdf | 12/24/2023 | 12/23/2026 |
| Kosher | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | OUV2-BE21A1E.pdf | 11/21/2023 | 5/31/2024 |
| Label Claims | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Packaging.pdf | 6/3/2020 | 6/3/2022 |
| Label Sample | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Packing Spec for VC-CA.pdf | 6/11/2021 | 6/11/2022 |
| Label Guidance | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Packing Spec for VC-CA.pdf | 6/3/2020 | 6/3/2022 |
| Pesticide | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Pestiside Statement-VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| Phthalate Esters Letter | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Phthalate free Statement-VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| California Prop. 65 | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | PROP 65 Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| California Prop. 65 | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | PROP 65 Statement--VC CA.pdf | 7/30/2021 | 7/30/2023 |
| Residual Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Residual Solvent Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2024 |
| Residual Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Residual Test Report.pdf | 6/11/2021 | 6/11/2022 |
| Safety Data Sheet (SDS) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SDS.pdf | 6/3/2020 | 6/3/2022 |
| Sewage Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Sewage Sludge Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| Sewage Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Sewage Sludge Statement.pdf | 6/3/2020 | 6/3/2022 |
| Shelf Life | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | shelf life Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| Heavy Metal | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SPEC.pdf | 6/3/2020 | 6/3/2022 |
| Product Specification Sheet | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SPEC.pdf | 6/3/2020 | 6/3/2023 |
| Shelf Life | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SPEC.pdf | 6/3/2020 | 6/3/2022 |
| Suitability Requirements | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Suitability Requirements.pdf | 2/17/2020 | 2/16/2023 |
| Suitability Requirements | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Suitability Requirements.pdf | 12/24/2023 | 12/23/2026 |
| Natural | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Synthetic Statement.pdf | 6/11/2021 | 6/11/2022 |
| BSE - TSE | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | TSE BSE VC-CA-03.pdf | 12/24/2023 | 12/23/2026 |
| BSE - TSE | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | TSE BSE.pdf | 5/13/2020 | 5/13/2023 |
| WADA/NSF/NFL Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | WADA Statement VC-CA-03.pdf | 12/24/2023 | 12/23/2025 |
| WADA/NSF/NFL Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | WADA Statement.pdf | 6/3/2020 | 6/3/2022 |
